Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

1.56
+0.03502.30%
Volume:298.58K
Turnover:466.94K
Market Cap:123.79M
PE:32.29
High:1.59
Open:1.57
Low:1.55
Close:1.52
Loading ...
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 12, 2020

Major Issues Report

Current report, items 1.01, 3.02, 8.01, and 9.01
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 20, 2019

Major Issues Report

Current report, items 3.03, 5.03, and 9.01
Dec 19, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Dec 09, 2019

Major Issues Report

Current report, items 5.07, 8.01, and 9.01
Nov 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 30, 2019

Major Issues Report

Current report, items 3.01 and 9.01
Aug 13, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]